Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.15.6321

Activation of JNK/p38 Pathway is Responsible for α-Methyl-n-butylshikonin Induced Mitochondria-Dependent Apoptosis in SW620 Human Colorectal Cancer Cells  

Wang, Hai-Bing (National Clinical Research Base of Traditional Chinese Medicine, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University)
Ma, Xiao-Qiong (National Clinical Research Base of Traditional Chinese Medicine, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.15, 2014 , pp. 6321-6326 More about this Journal
Abstract
${\alpha}$-Methyl-n-butylshikonin (MBS), one of the active components in the root extracts of Lithospermum erythrorhizon, posses antitumor activity. In this study, we assess the molecular mechanisms of MBS in causing apoptosis of SW620 cells. MBS reduced the cell viability of SW620 cells in a dose-and time-dependent manner and induced cell apoptosis. Treatment of SW620 cells with MBS down-regulated the expression of Bcl-2 and up-regulated the expression of Bak and caused the loss of mitochondrial membrane potential. Additionally, MBS treatment led to activation of caspase-9, caspase-8 and caspase-3, and cleavage of PARP, which was abolished by pretreatment with the pan-caspase inhibitor Z-VAD-FMK. MBS also induced significant elevation in the phosphorylation of JNK and p38. Pretreatment of SW620 cells with specific inhibitors of JNK (SP600125) and p38 (SB203580) abrogated MBS-induced apoptosis. Our results demonstrated that MBS inhibited growth of colorectal cancer SW620 cells by inducing JNK and p38 signaling pathway, and provided a clue for preclinical and clinical evaluation of MBS for colorectal cancer therapy.
Keywords
${\alpha}$-Methyl-n-butylshikonin; apoptosis; colorectal cancer; JNK; p38;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Brentnall M, Rodriguez-Menocal L, De Guevara RL, et al (2013). Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol, 14, 32.   DOI   ScienceOn
2 Baines CP, Molkentin JD (2005). STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol, 38, 47-62.   DOI   ScienceOn
3 Bennett BL1, Sasaki DT, Murray BW, et al (2001). SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A, 98, 13681-6.   DOI   ScienceOn
4 Chen J, Xie J, Jiang Z, et al (2011). Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2. Oncogene, 30, 4297-306.   DOI   ScienceOn
5 Chen X, Yang L, Zhang N, et al (2003). Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother, 47, 2810-6.   DOI   ScienceOn
6 Cory S, Adams JM (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer, 2, 647-56.   DOI   ScienceOn
7 Huang C, Luo Y, Zhao J, et al (2013). Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS One, 8, 66326.   DOI
8 Hsu PC, Huang YT, Tsai ML, et al (2004). Induction of apoptosis by shikonin through coordinative modulation of the Bcl-2 family, p27, and p53, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells. J Agric Food Chem, 52, 6330-7.   DOI   ScienceOn
9 Hu W, Kavanagh JJ (2003). Anticancer therapy targeting the apoptotic pathway. Lancet Oncol, 4, 721-9.   DOI   ScienceOn
10 Raman M, Chen W, Cobb MH (2007). Differential regulation and properties of MAPKs. Oncogene, 26, 3100-12.   DOI   ScienceOn
11 Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30.   DOI   ScienceOn
12 Shen CC, Syu WJ, Li SY, et al (2002). Antimicrobial activities of naphthazarins from Arnebia euchroma. J Nat Prod, 65, 1857-62.   DOI   ScienceOn
13 Ly JD, Grubb DR, Lawen A (2003). The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis, 8, 115-28.   DOI   ScienceOn
14 Shen XJ, Wang HB, Ma XQ, Chen JH (2012). $\beta$,$\beta$-Dimethylacrylshikonin induces mitochondria dependent apoptosis through ERK pathway in human gastric cancer SGC-7901 cells. PLoS One, 7, 41773.   DOI
15 Shimizu S, Narita M, Tsujimoto Y (1999). Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399, 483-7.   DOI   ScienceOn
16 Tanaka S, Tajima M, Tsukada M, Tabata M (1986). A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin. J Nat Prod, 49, 466-9.   DOI
17 Li M, Jiang XG, Gu ZL, Zhang ZB (2013). Glaucocalyxin A activates FasL and induces apoptosis through activation of the JNK pathway in human breast cancer cells. Asian Pac J Cancer Prev, 14, 5805-10.   과학기술학회마을   DOI   ScienceOn
18 Ola MS, Nawaz M, Ahsan H (2011). Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem, 351, 41-58.   DOI
19 Wang R, Yin R, Zhou W, et al (2012). Shikonin and its derivatives: a patent review. Expert Opin Ther Pat, 22, 977-97.   DOI   ScienceOn
20 Wada T, Penninger JM (2004). Mitogen-activated protein kinases in apoptosis regulation. Oncogene, 23, 2838-49.   DOI   ScienceOn
21 Xia Z, Dickens M, Raingeaud J, (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-31.   DOI   ScienceOn
22 Hsieh CJ, Kuo PL, Hsu YC, et al (2014). Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptornegative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation. Free Radic Biol Med, 67, 159-70.   DOI   ScienceOn
23 Xuan Y, Hu X (2009). Naturally-occurring shikonin analogues-a class of necroptotic inducers that circumvent cancer drug resistance. Cancer Lett, 274, 233-42.   DOI   ScienceOn
24 Zeng Y, Liu G, Zhou LM (2009). Inhibitory effect of acetylshikonin on human gastric carcinoma cell line SGC-7901 in vitro and in vivo. World J Gastroenterol, 15, 1816-20.   DOI
25 Hu F, Han J, Zhai B, et al (2014). Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation. Apoptosis, 19, 210-23.   DOI   ScienceOn
26 Igney FH, Krammer PH (2002). Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer, 2, 277-88.   DOI   ScienceOn
27 Ko FN, Lee YS, Kuo SC, et al (1995). Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma. Biochim Biophys Acta, 1268, 329-34.   DOI   ScienceOn
28 Kayali AG, Austin DA, Webster NJ (2000). Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. Diabetes, 49, 1783-93.   DOI   ScienceOn
29 Andujar I, Recio MC, Giner RM, Rios JL (2013). Traditional chinese medicine remedy to jury: the pharmacological basis for the use of shikonin as an anticancer therapy. Curr Med Chem, 20, 2892-8.   DOI
30 Avisetti DR, Babu KS, Kalivendi SV (2014). Activation of p38/JNK pathway is responsible for embelin induced apoptosis in lung cancer cells: transitional role of reactive oxygen species. PLoS One, 9, 87050.   DOI
31 Tournier C, Hess P, Yang DD, et al (2000). Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science, 288, 870-4.   DOI   ScienceOn
32 Tait SW, Green DR (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol , 11, 621-32.   DOI   ScienceOn
33 Mantena SK, Sharma SD, Katiyar SK (2006). Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase-3 and PARP. Carcinogenesis, 27, 2018-27.   DOI   ScienceOn